- Home
- CVAC vs TBLD Comparison
CVAC vs TBLD Comparison
Compare CVAC & TBLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- TBLD
- Stock Information
- Founded
- CVAC 2000
- TBLD 2021
- Country
- CVAC Germany
- TBLD United States
- Employees
- CVAC N/A
- TBLD N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- TBLD Investment Managers
- Sector
- CVAC Health Care
- TBLD Finance
- Exchange
- CVAC Nasdaq
- TBLD Nasdaq
- Market Cap
- CVAC 637.1M
- TBLD 530.3M
- IPO Year
- CVAC 2020
- TBLD N/A
- Fundamental
- Price
- CVAC $2.95
- TBLD $16.41
- Analyst Decision
- CVAC Hold
- TBLD
- Analyst Count
- CVAC 3
- TBLD 0
- Target Price
- CVAC $10.00
- TBLD N/A
- AVG Volume (30 Days)
- CVAC 523.1K
- TBLD 99.9K
- Earning Date
- CVAC 11-12-2024
- TBLD 01-01-0001
- Dividend Yield
- CVAC N/A
- TBLD 7.85%
- EPS Growth
- CVAC N/A
- TBLD N/A
- EPS
- CVAC N/A
- TBLD N/A
- Revenue
- CVAC $70,565,734.00
- TBLD N/A
- Revenue This Year
- CVAC $738.59
- TBLD N/A
- Revenue Next Year
- CVAC N/A
- TBLD N/A
- P/E Ratio
- CVAC N/A
- TBLD N/A
- Revenue Growth
- CVAC 75.11
- TBLD N/A
- 52 Week Low
- CVAC $2.22
- TBLD $13.44
- 52 Week High
- CVAC $5.28
- TBLD $16.26
- Technical
- Relative Strength Index (RSI)
- CVAC 49.55
- TBLD 34.01
- Support Level
- CVAC $3.17
- TBLD $16.44
- Resistance Level
- CVAC $3.56
- TBLD $16.85
- Average True Range (ATR)
- CVAC 0.18
- TBLD 0.24
- MACD
- CVAC 0.01
- TBLD -0.02
- Stochastic Oscillator
- CVAC 24.69
- TBLD 5.52
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About TBLD Thornburg Income Builder Opportunities Trust
Thornburg Income Builder Opportunities Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income. The Trust will seek to achieve its investment objective by investing, directly or indirectly, at least 80% of its Managed Assets.